ARNA combines the power of blockchain and smart contracts to provide a robust ecosystem that provides cancer detection methods

What is Arna Genomics?


ARNA Genomics is an innovative biotechnology company, launched by a team of scientists and entrepreneurs alike and grew from a scientific research and research laboratory into a full-scale business. We developed a revolutionary early detection method for cancer of choice to launch a series of diagnostic tests for early cancer detection in global markets.

Mission Of Genomics ARNA


to increase life expectancy and significantly reduce human mortality. We are constantly pursuing this goal through cutting-edge screening methods, diagnostic corrections, treatment monitoring, and patient adherence enhancement.

Innovation Of Genomics ARNA


ARNA Genomics has found a technology that allows the development of very specific tests for different types of cancer. In addition, the company has also developed a unique concept of blockchain-based classroom platform intended to be used as an instrument to support R & D and application of biotechnology technology worldwide.

The ARNA Genomic Pledge


ARNA Genomics has completed R & D for its first product - an ARNA breast cancer test. The test for colon cancer test is currently in advanced R & D stage. We devote all our resources to complete the development of ARNA Panacea - the blockchain platform, which is expected to change the world by launching new and simpler biotech solutions and treatments against cancer, cheaper and faster.

The development of ARNA is efficacious

ARNA Genomics will provide all market participants working with cancer as a fundamental new way to access and interact with data collection and storage of clinical trials. Using a token ARNA holder will be able to pay service members on other systems (eg cancer checks, tests, etc.), Gaining access to data storage systems for medical experiments for the use of medical professionals, paying other service users. system or start fundraising for a new study.

In collaboration with our FDA (Food and Drug Administration) regulator, the ARNA genome will test the appropriate data storage system to gather an evolutionary base that regulators will use to get more ARNA BC breast cancer detection products to the US. general market. ARNA Genomics will use the existing methodology and "best practices" for successful development and implementation of this solution to all members of the ARPA Panacea ecosystem:
  • Discuss and discover: the first phase of the project will include discussion and evaluation of key market players in terms of adaptation of Blockchain technology, as well as all technical requirements.
  • Prototype design: this phase & deals with the development of a Blockchain node prototype with a trusted partner to evaluate and conduct an ARNA efficacy test thoroughly.
  • Development: the development of the model base system will be completed during this phase.
  • Usage: this stage involves the use of the mangosteen ecosystem as well as the involvement of new ARNA partners and market participants.
  • Application Support: ARNA Genomics will continue to support the system and its members for a limited period of time.
ARNA ECOSYSTEM


The Arna ecosystem consists of 3 key elements.
  1. ARNA BC: The Arna BC test (breast cancer) is able to diagnose breast cancer at all stages, including the earliest through a specific blood plasma analysis. Laboratory sensitivity and specificity of ARNA BC are both approaching 95%. What this means is that the current ARNA BC does not even have a tough competition in terms of its efficiency among other available tests or in the development
  2. ARNA Panacea: a platform designed to collect, store and analyze information about available and new cancer methods and detection around the world. Data is stored in blockchain and available to all system users who have access to ARNA Panacea. Users can gain access to different levels and different types of data, depending on the user's role in the system and their direct relation to the data.

TOKEN ARNA

ARNA is an open source cryptographic token designed as crypto currency intended to be used as a means of payment for the services of Panacea ARNA platform members as well as one of the payment methods for the ARNA BC test after its market launch. The ARNA Token will be the accounting unit in all economic transactions of the ARZA Panoramaa Blockchain platform and will serve as the basis for interactions with market participants and other clinical trials, including human DNA research.
As described below, most of the ARNA token money supplies will be available in the near future, as some of the ARNA tokens will be reserved for ARNA Genomics payment vehicles. Like other crypto currencies, ARNA tokens can be exchanged and transferable; Their placement in the crypto currency market is expected.
DISTRIBUTION TOKEN
Token Sale start: December 15, 2017
Token Sale end: February 10, 2018
To participate you must fill the Crowdsale Waitlist on ARNA Genomics WEBSITE.
Token distribution date: February 10, 2017
Token Fee: 0.000266 ETH
Payment methods accepted: Ethereal (ETH)
Token sales target: 17890
Genesis Distribution Token: 500,000,000 ARNA
USE OF TOKEN
The ARNA Token is used to pay for system interactions (data entry, gain access to research conducted, etc.) by all its members. The ARNA utility toll is also used as a way for ARNA patients to pay for cancer screening with a BC ARNA test at partner clinics and laboratories worldwide paid with ARNA tokens. The screening results will also be provided to Patients via a platform in the personal account portion of the site or in the mobile application.
Patients will be able to provide access to their personal data, including medical history and clinical data on their treatment, to participate in new research conducted by ARA pharmaceuticals. Sponsors may use ARNA token to fund clinical trials of the latest cancer treatment technologies and techniques. Investigators may also receive payments based on the results of successful clinical trials of this method from sales proceeds.
We intend to promote ARNA token as the real preferred currency for Pharmaceutical companies that allow payment on ARNA tokens for their own research (when acting as Investigators), as it uses research results (to the Investigator and Health Clinic to access patient data) as well as to use other methods on this site. In the Panacea ARNA development process, additional ways to use ARNA tokens and valuable Token holders can be defined or redefined.
ROADMAP

FOR MORE CLEARLY PLEASE VISIT LINKS BELOW:



diah permatasari
my ETH: 0xeac14bD54cC94d815c770Bd91efD8feC0572E52B

Komentar